NCT00433875已完成2 期
A Double-Blind, Placebo Controlled, Randomized, Parallel-Group Clinical Trial With Multiple Dose Treatment of Anti-IL 15 Human Monoclonal Antibody (AMG 714) in Patients With Active Rheumatoid Arthritis Who Have Previously Failed One or More Disease Modifying Anti-Rheumatic Drugs
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 180
研究概览
简要总结
Twelve week treatment of AMG 714 in RA patients who failed at least one DMARD, followed by a 3 month observational period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of RA -
排除标准
- •No prior biologic treatment for RA
研究者
相似试验
已完成
2 期
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac DiseaseCeliac DiseaseNCT02637141Amgen64
已完成
2 期
DRIVERheumatoid ArthritisJPRN-jRCT2080221226DAIICHISANKYO Co.,Ltd.346
已完成
2 期
12-month Study of AMG 073 in Renal OsteodystrophyRenal OsteodystrophyNCT00527085Amgen45
尚未招募
2 期
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS PatientsRespiratory Distress SyndromeRespiratory Tract DiseasesCytokine StormRespiratory FailureAcute Respiratory Distress SyndromeNCT06308926MedRegen LLC60
已完成
2 期
Phase II Study to Evaluate the Efficacy of AMG 317AsthmaNCT00436670Amgen294